About Connex Pharma
Data last updated:
Connex Pharma is a company. Connex Pharma offers products and services including Hexamethyldisilazane (HMDS) and Chloromethyl Isopropyl Carbonate (CMIC).
- SectorsChemicals & Materials
- EmailLocked
- PhoneLocked
- SocialLocked
- Legal Name Connex Pharma Private Ltd
- Jurisdiction Visakhapatnam, Andhra Pradesh, India
- Annual Revenue$8.79 M (USD)146.59as on Mar 31, 2022
- Net Profit$350.73 K (USD)5.21as on Mar 31, 2022
- EBITDA$3.09 M (USD)59.81as on Mar 31, 2022
- Latest Funding RoundNot available
- InvestorsNot available
- Employee CountNot available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Connex Pharma
Connex Pharma offers a comprehensive portfolio of products and services, including Hexamethyldisilazane (HMDS) and Chloromethyl Isopropyl Carbonate (CMIC).
It is produced as a versatile organosilicon compound that is utilized in various applications.
It is employed in the production process of antiviral medications like Tenofovir.
Funding Insights of Connex Pharma
Detailed funding history for Connex Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Connex Pharma
Investment portfolio details for Connex Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Connex Pharma
Detailed financials for Connex Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Connex Pharma Comparisons
Peer comparison for Connex Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Connex Pharma
Detailed competitors of Connex Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Connex Pharma
Complete news archive for Connex Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Connex Pharma
Annual revenue of Connex Pharma is $8.79M as on Mar 31, 2022.
Connex Pharma is operated as a manufacturer of pharmaceutical intermediates from a 5.4-acre facility in Vishakhapatnam, Andhra Pradesh, with certifications under ISO 9001:2015 and ISO 14001:2015. Specialty chemicals like Hexamethyldisilazane and Chloromethyl Isopropyl Carbonate are produced using state-of-the-art instruments, while adherence to Good Manufacturing Practices is maintained for secure processes. The company is also registered with D-U-N-S and serves global markets through its network, ensuring reliable operations in the chemicals sector. A focus on safe production methods is evident in its activities.
Connex Pharma offers Hexamethyldisilazane (HMDS) and Chloromethyl Isopropyl Carbonate (CMIC).